ImmunityBio Shares Are Trading Higher After the Company Announced It Signed an Exclusive Global Arrangement With the Serum Institute of India. The Company Will Be Supplied With Bacillus Calmette-Guerin
ImmunityBio宣佈與印度血清研究所簽署獨家全球協議後,該公司股價走高。該公司將獲得 Calmette-Guerin 芽孢桿菌